Author details

Full Name

Keren Levanon

Affiliation

ORCID

Career Start Year

2001

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36638243	The Role of 68 Ga-FAPI PET/CT in Detection of Metastatic Lobular Breast Cancer.		2023
36214786	Proteomic signature for detection of high-grade ovarian cancer in germline BRCA mutation carriers.	Int J Cancer	2023
38085049	Lasofoxifene Monotherapy Induces Durable Complete Remission in a Patient with Estrogen Receptor-Positive, Metastatic Breast Cancer with an Mutation.		2023
37339456	The Role of 68 Ga-FAPI PET/CT in Breast Cancer Response Assessment and Follow-Up.		2023
34998206	RNA biomarkers from proximal liquid biopsy for diagnosis of ovarian cancer.	Neoplasia	2022
34621946	Concomitant diagnosis of endometrial and breast cancer - does the sequence matters?	Gynecologic Oncology Reports	2021
33941851	Targeting autocrine amphiregulin robustly and reproducibly inhibits ovarian cancer in a syngeneic model: roles for wildtype p53.	Oncogene	2021
33257015	Candidate RNA biomarkers in biofluids for early diagnosis of ovarian cancer: A systematic review.	Gynecologic Oncology	2021
32614381	NF-ÎºB-miR-155 axis activation mediates ovulation-induced oncogenic effects in fallopian tube epithelium.	Carcinogenesis	2020
32303989	Diagnostic yield of multigene panel testing in an Israeli cohort: enrichment of low-penetrance variants.	Breast Cancer Research and Treatment	2020
32467386	The human tumor microbiome is composed of tumor type-specific intracellular bacteria.	Science	2020
31044156	Resistance to paclitaxel is associated with a variant of the gene BCL2 in multiple tumor types.	npj Precision Oncology	2019
30760538	Microvesicle Proteomic Profiling of Uterine Liquid Biopsy for Ovarian Cancer Early Detection.	Mol Cell Proteomics	2019
31387980	Proteomic and genomic signatures of repeat instability in cancer and adjacent normal tissues.	Proc Natl Acad Sci U S A	2019
29800932	Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.	Breast	2018
29379162	PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma.	Oncogene	2018
28977941	CCNE1 expression in high grade serous carcinoma does not correlate with chemoresistance.	Oncotarget	2017
26936395	Activation-Induced Cytidine Deaminase Links Ovulation-Induced Inflammation and Serous Carcinogenesis.	Neoplasia	2016
25915843	An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.	Oncogene	2016
25804953	Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci.	Hum Mol Genet	2015
24077281	FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.	Oncogene	2014
24355484	Exposure of fallopian tube epithelium to follicular fluid mimics carcinogenic changes in precursor lesions of serous papillary carcinoma.	Gynecologic Oncology	2014
23257362	Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.	J Clin Invest	2013
21610668	Ex vivo culture of primary human fallopian tube epithelial cells.	J Vis Exp	2011
21502498	Modeling high-grade serous ovarian carcinogenesis from the fallopian tube.	Proc Natl Acad Sci U S A	2011
21683992	Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.	Gynecol Oncol	2011
19935705	Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis.	Oncogene	2010
18854563	New insights into the pathogenesis of serous ovarian cancer and its clinical impact.	J Clin Oncol	2008
17085959	Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.	Pathobiology	2006
16138094	Letter from the editor: Adenosine-to-inosine RNA editing in Alu repeats in the human genome.	EMBO Reports	2005
16157225	Inhibition of carcinogenesis in transgenic mouse models over-expressing 15-lipoxygenase in the vascular wall under the control of murine preproendothelin-1 promoter.	Cancer Letters	2005
15057308	Transcription-controlled gene therapy against tumor angiogenesis.	Journal of Clinical Investigation	2004
11423929	Tissue-specific gene therapy directed to tumor angiogenesis.	Gene Therapy	2001